These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7860391)

  • 21. Brachytherapy Combined With Surgery for Conservative Treatment of Children With Bladder Neck and/or Prostate Rhabdomyosarcoma.
    Chargari C; Haie-Meder C; Guérin F; Minard-Colin V; de Lambert G; Mazeron R; Escande A; Marsolat F; Dumas I; Deutsch E; Valteau-Couanet D; Audry G; Oberlin O; Martelli H
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):352-359. PubMed ID: 28463154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensity modulated radiation therapy with dose painting to treat rhabdomyosarcoma.
    Yang JC; Dharmarajan KV; Wexler LH; La Quaglia MP; Happersett L; Wolden SL
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e371-7. PubMed ID: 22658517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001).
    Abd El-Aal HH; Habib EE; Mishrif MM
    J Egypt Natl Canc Inst; 2006 Mar; 18(1):51-60. PubMed ID: 17237856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term morbidity in children treated with fractionated high-dose-rate brachytherapy for soft tissue sarcomas.
    Nag S; Tippin D; Ruymann FB
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):448-52. PubMed ID: 12794522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.
    Raney RB; Meza J; Anderson JR; Fryer CJ; Donaldson SS; Breneman JC; Fitzgerald TJ; Gehan EA; Michalski JM; Ortega JA; Qualman SJ; Sandler E; Wharam MD; Wiener ES; Maurer HM; Crist WM
    Med Pediatr Oncol; 2002 Jan; 38(1):22-32. PubMed ID: 11835233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
    Rodeberg DA; Wharam MD; Lyden ER; Stoner JA; Brown K; Wolden SL; Paidas CN; Donaldson SS; Hawkins DS; Spunt SL; Arndt CA
    Int J Cancer; 2015 Jul; 137(1):204-11. PubMed ID: 25418440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conservative surgical management of vaginal and vulvar pediatric rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study III.
    Andrassy RJ; Hays DM; Raney RB; Wiener ES; Lawrence W; Lobe TE; Corpron CA; Smith M; Maurer HM
    J Pediatr Surg; 1995 Jul; 30(7):1034-6; discussion 1036-7. PubMed ID: 7472927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pediatric rhabdomyosarcoma of the infratemporal fossa].
    Rozan O; Janot F; Oberlin O; Schwaab G; Quintana E; Tran Ba Huy P; Georges B; Luboinski B
    Ann Otolaryngol Chir Cervicofac; 2002 Sep; 119(4):195-201. PubMed ID: 12410115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiocurability of microscopic disease in childhood rhabdomyosarcoma with radiation doses less than 4,000 cGy.
    Mandell L; Ghavimi F; Peretz T; LaQuaglia M; Exelby P
    J Clin Oncol; 1990 Sep; 8(9):1536-42. PubMed ID: 2391558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Improved local tumor control by early and risk-adjusted use of radiotherapy in primary non-resectable rhabdomyosarcomas: results of CWS 81 and 86 studies].
    Koscielniak E; Herbst M; Niethammer D; Treuner J
    Klin Padiatr; 1994; 206(4):269-76. PubMed ID: 7967423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
    Wolden SL; Anderson JR; Crist WM; Breneman JC; Wharam MD; Wiener ES; Qualman SJ; Donaldson SS
    J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Weigel BJ; Lyden E; Anderson JR; Meyer WH; Parham DM; Rodeberg DA; Michalski JM; Hawkins DS; Arndt CA
    J Clin Oncol; 2016 Jan; 34(2):117-22. PubMed ID: 26503200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local control of parameningeal rhabdomyosarcoma: outcomes in non-complete responders to chemoradiation.
    Paulino AC; Bauman N; Simon JH; Nguyen TX; Ritchie JM; Tannous R
    Med Pediatr Oncol; 2003 Aug; 41(2):118-22. PubMed ID: 12825215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of sarcomas of the chest wall using intensive combined modality therapy.
    Young MM; Kinsella TJ; Miser JS; Triche TJ; Glaubiger DL; Steinberg SM; Glatstein E
    Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):49-57. PubMed ID: 2643597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.
    Wilder RB; Tucker SL; Ha CS; Rodriguez MA; Hess MA; Cabanillas FF; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):17-22. PubMed ID: 11163493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.
    Chen C; Shu HK; Goldwein JW; Womer RB; Maity A
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1294-9. PubMed ID: 12654440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Third Intergroup Rhabdomyosarcoma Study.
    Crist W; Gehan EA; Ragab AH; Dickman PS; Donaldson SS; Fryer C; Hammond D; Hays DM; Herrmann J; Heyn R
    J Clin Oncol; 1995 Mar; 13(3):610-30. PubMed ID: 7884423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conservative management of uterine pediatric rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study III and IV pilot.
    Corpron CA; Andrassy RJ; Hays DM; Raney RB; Wiener ES; Lawrence W; Lobe TE; Maurer HM
    J Pediatr Surg; 1995 Jul; 30(7):942-4. PubMed ID: 7472949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma.
    Boulad F; Kernan NA; LaQuaglia MP; Heller G; Lindsley KL; Rosenfield NS; Abramson SJ; Gerald WL; Small TN; Gillio AP; Gulati SC; O'Reilly RJ; Ghavimi F
    J Clin Oncol; 1998 May; 16(5):1697-706. PubMed ID: 9586881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of alternating chemotherapy and hyperfractionated radiation therapy in childhood rhabdomyosarcoma.
    Merchant TE; Cahill JC; Ghavimi F
    Med Pediatr Oncol; 1998 Jun; 30(6):332-8. PubMed ID: 9589081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.